Previous Close | 39.05 |
Open | 39.05 |
Bid | 38.84 x 400 |
Ask | 38.91 x 200 |
Day's Range | 38.38 - 39.31 |
52 Week Range | 15.44 - 40.21 |
Volume | |
Avg. Volume | 1,494,724 |
Market Cap | 6.629B |
Beta (5Y Monthly) | 1.54 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
On May 3, 2024, Jack Anders, the Chief Financial Officer of Revolution Medicines Inc (NASDAQ:RVMD), sold 10,000 shares of the company.
Revolution Medicines, Inc. (NASDAQ:RVMD) Q4 2023 Earnings Call Transcript February 26, 2024 Revolution Medicines, Inc. misses on earnings expectations. Reported EPS is $-1.14 EPS, expectations were $-0.86. Revolution Medicines, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day […]
Revolution Medicines ( NASDAQ:RVMD ) Full Year 2023 Results Key Financial Results Revenue: US$11.6m (down 67% from FY...